Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA Healthcare Businesswomen’s Association Shines a Light on Lynn Hamilton and Katya Magonova May 06, 2021 07:30 ET | Source: Syneos Health, Inc. Syneos Health, Inc. MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior Director, Clinical Operations and Clinical Development Services, and Katya Magonova, MBA, Senior Engagement Manager, Commercial Advisory Group, have been recognized by the Healthcare Businesswomen’s Association (HBA) as exemplary female leaders in the biopharmaceutical industry for 2021. “While it was a tough decision to choose amongst a long list of women leaders across the organization, Lynn and Katya stood out. Both of these women are strong leaders, with exceptional talents, who continue to serve as role models through their commitment to the business and by living our Values,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “We’re thrilled to see women leaders who embody the inclusive and collaborative leadership style that we cultivate at Syneos Health represented externally by our corporate partners.”